Patent Application Titled "Il-13ralpha2 Targeted Immunotoxins And Methods Of Use" Published Online (USPTO 20240239857).

A patent application titled "Il-13ralpha2 Targeted Immunotoxins And Methods Of Use" has been published online by the United States Patent and Trademark Office. The patent application describes immunotoxins that specifically bind to IL-13Ra2, a protein associated with certain cancers. These immunotoxins are linked to cytotoxic proteins and can be used to treat IL-13Ra2-expressing tumors or cancers, as well as reduce perineural invasion and associated pain. The patent application also includes information on nucleic acids, vectors, host cells, and methods of producing and administering the immunotoxins. [Extracted from the article]